Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 5.89x is 11% below its 4-year average of 6.59x, around the middle of its 4-year range (-32.25x–80.00x).
77.85% below its 12-month average of 26.59x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 80.00x.
INTEREST COVERAGE RATIO
5.89x
INTEREST COVERAGE RATIO AVG TTM
26.59x
INTEREST COVERAGE RATIO AVG 3Y
6.07x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-77.85%
CURRENT VS 3Y AVG
-3.02%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.12x
median of 422 covered companies
CURRENT VS SECTOR MEDIAN
+215.15%
vs the sector median at left
Indivior Pharmaceuticals Inc
Market Cap
$4.44B
Interest Coverage Ratio
5.89x
TTM Avg
26.59x
3Y Avg
6.07x
5Y Avg
N/A
Market Cap
$4.41B
Interest Coverage Ratio
-4.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.38B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.34B
Interest Coverage Ratio
-4.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Interest Coverage Ratio
5.35x
TTM Avg
5.33x
3Y Avg
5.03x
5Y Avg
4.13x
Market Cap
$4.59B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
Market Cap
$4.68B
Interest Coverage Ratio
2.07x
TTM Avg
2.07x
3Y Avg
2.07x
5Y Avg
1.38x
Market Cap
$4.15B
Interest Coverage Ratio
4.05x
TTM Avg
3.05x
3Y Avg
3.05x
5Y Avg
3.05x
Market Cap
$4.72B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.44B | 5.89x | 26.59x | 6.07x | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | -4.85x | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | N/A | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.34B | -4.22x | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 5.35x | 5.33x | 5.03x | 4.13x |
| BillionToOne, Inc. (BLLN)vs › | $4.59B | 168.66x | 168.66x | 168.66x | 168.66x |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 2.07x | 2.07x | 2.07x | 1.38x |
| LivaNova PLC (LIVN)vs › | $4.15B | 4.05x | 3.05x | 3.05x | 3.05x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.72B | -30.34x | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.10B | N/A | 46.33x | 38.87x | 38.87x |
Interest Coverage
5.9x
Debt/Equity
N/A
Current Ratio
0.84
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 80.00x |
| 2026-03-31 | 19.57x |
| 2025-12-31 | 20.33x |
| 2025-09-30 | 8.25x |
| 2025-06-30 | 4.80x |
| 2025-03-31 | 5.50x |
| 2024-12-31 | 7.38x |
| 2024-09-30 | 0.40x |
| 2024-06-30 | -13.11x |
| 2024-03-31 | 9.38x |
| 2023-12-31 | 6.78x |
| 2023-09-30 | -18.30x |
| 2023-06-30 | 6.10x |
| 2023-03-31 | 5.70x |
| 2022-12-31 | -32.25x |
| 2022-09-30 | 7.00x |
| 2022-06-30 | 9.00x |
| 2022-03-31 | 9.00x |
| 2021-12-31 | 6.43x |
